Refractory haEmorrhage Devices trial: a multi-arm, multi-stage, multicentre randomized active controlled superiority trial to evaluate the efficacy of uterine tamponade devices for the management of refractory postpartum haemorrhage. (RED trial)

Overview

The objective of this trial is to compare the efficacy of three uterine tamponade devices (Ellavi® free-flow, Ellavi® fixed-volume, or STUT) with that of the site specific improvised UBT (Foley catheter), in reducing the incidence of severe maternal morbidity or mortality in women who delivered vaginally and were diagnosed with atonic refractory PPH.